|
 |
|
|||||||
|
|||||||||
Correspondence to:
Ingemar Björkhem.
We have previously demonstrated that the brain contains about 80% of the 24S-hydroxycholesterol in the human body and that there is a net flux of this steroid from the brain into the circulation (Lütjohann, D. et al. 1996. Proc. Natl. Acad. Sci. USA. 93: 9799–9804). Combining previous data with new data on 12 healthy volunteers, the arteriovenous difference between levels of this oxysterol in the internal jugular vein and in a peripheral artery was found to be -10.2 ± 2.8 ng/ml (mean ± SEM) corresponding to a net flux of 24S-hydroxycholesterol from the brain of about 6.4 mg/24 h. The arteriovenous difference between levels of 24S-hydroxycholesterol in the hepatic vein and a peripheral artery of 12 other volunteers was found to be 7.4 ± 2.2 ng/ml, corresponding to a hepatic uptake of about 7.6 mg/24 h. The concentrations of 24S-hydroxycholesterol in the renal vein were about the same as those in a peripheral artery, indicating that a renal elimination is not of importance. Intravenously injected deuterium-labeled racemic 24-hydroxycholesterol was eliminated from the circulation of two human volunteers with half-lives of 10 h and 14 h, respectively. A positive correlation was found between the levels of circulating cholesterol and 24S-hydroxycholesterol.
The results are consistent with a cerebral origin of most of the circulating 24S-hydroxycholesterol and suggest that the liver is the major eliminating organ. It is concluded that conversion into 24S-hydroxycholesterol is a quantitatively important mechanism for elimination of cholesterol from human brain. The possibility is discussed that circulating levels of 24S-hydroxycholesterol can be used as a marker for pathological and/or developmental changes in the brain.—Björkhem, I., D. Lütjohann, U. Diczfalusy, L. Ståhle, G. Ahlborg, and J. Wahren. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 1998. 39: 1594–1600.
Supplementary key words:
brain cholesterol, cytochrome P-450, myelin, isotope dilution–mass spectrometry
Copyright © 1998 by Lipid Research, Inc.
Original Article
Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation
Ingemar Björkhema,
Dieter Lütjohanna,
Ulf Diczfalusya,
Lars Ståhleb,
Gunvor Ahlborgc, and
John Wahrend
a Divisions of Clinical Chemistry, Clinical Pharmacology, Huddinge University Hospital, SE-141 86, Huddinge, Sweden
b Divisions of Clinical Chemistry, Clinical Physiology, Huddinge University Hospital, SE-141 86, Huddinge, Sweden
c Divisions of Clinical Chemistry, Karolinska Institute, Huddinge University Hospital, SE-141 86, Huddinge, Sweden
d Division of Clinical Physiology, Karolinska Institute, Karolinska Hospital, Stockholm, Sweden
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. W. Russell Fifty years of advances in bile acid synthesis and metabolism J. Lipid Res., April 1, 2009; 50(Supplement): S120 - S125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Benarroch Brain cholesterol metabolism and neurologic disease Neurology, October 21, 2008; 71(17): 1368 - 1373. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mast, M. A. White, I. Bjorkhem, E. F. Johnson, C. D. Stout, and I. A. Pikuleva Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain PNAS, July 15, 2008; 105(28): 9546 - 9551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Repa, H. Li, T. C. Frank-Cannon, M. A. Valasek, S. D. Turley, M. G. Tansey, and J. M. Dietschy Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse J. Neurosci., December 26, 2007; 27(52): 14470 - 14480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Valenza, J. B. Carroll, V. Leoni, L. N. Bertram, I. Bjorkhem, R. R. Singaraja, S. Di Donato, D. Lutjohann, M. R. Hayden, and E. Cattaneo Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation Hum. Mol. Genet., September 15, 2007; 16(18): 2187 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Hirsch-Reinshagen, J. Y. Chan, A. Wilkinson, T. Tanaka, J. Fan, G. Ou, L. F. Maia, R. R. Singaraja, M. R. Hayden, and C. L. Wellington Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-{beta} peptide levels in vivo J. Lipid Res., April 1, 2007; 48(4): 914 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohyama, S. Meaney, M. Heverin, L. Ekstrom, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, et al. Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1): MARKED INSENSITIVITY TOWARD DIFFERENT REGULATORY AXES J. Biol. Chem., February 17, 2006; 281(7): 3810 - 3820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Heverin, S. Meaney, D. Lutjohann, U. Diczfalusy, J. Wahren, and I. Bjorkhem Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain J. Lipid Res., May 1, 2005; 46(5): 1047 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-i. Ito, Y. Nagayasu, R. Lu, A. Kheirollah, M. Hayashi, and S. Yokoyama Astrocytes produce and secrete FGF-1, which promotes the production of apoE-HDL in a manner of autocrine action J. Lipid Res., April 1, 2005; 46(4): 679 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Reiss Cholesterol and apolipoprotein E in Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2005; 20(2): 91 - 96. [Abstract] [PDF]
|
|
|
|
|
|
H. Kolsch, M. Linnebank, D. Lutjohann, F. Jessen, U. Wullner, U. Harbrecht, K. M. Thelen, M. Kreis, F. Hentschel, A. Schulz, et al. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke Neurology, December 28, 2004; 63(12): 2255 - 2260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Hirsch-Reinshagen, S. Zhou, B. L. Burgess, L. Bernier, S. A. McIsaac, J. Y. Chan, G. H. Tansley, J. S. Cohn, M. R. Hayden, and C. L. Wellington Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain J. Biol. Chem., September 24, 2004; 279(39): 41197 - 41207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mano, Y. Sato, M. Nagata, T. Goto, and J. Goto Bioconversion of 3{beta}-hydroxy-5-cholenoic acid into chenodeoxycholic acid by rat brain enzyme systems J. Lipid Res., September 1, 2004; 45(9): 1741 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bjorkhem and S. Meaney Brain Cholesterol: Long Secret Life Behind a Barrier Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 806 - 815. [Abstract] [Full Text]
|
|
|
|
|
|
I. Burkard, K. M. Rentsch, and A. von Eckardstein Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry J. Lipid Res., April 1, 2004; 45(4): 776 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Heverin, N. Bogdanovic, D. Lutjohann, T. Bayer, I. Pikuleva, L. Bretillon, U. Diczfalusy, B. Winblad, and I. Bjorkhem Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease J. Lipid Res., January 1, 2004; 45(1): 186 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J Miller and R. Chacko The Role of Cholesterol and Statins in Alzheimer's Disease Ann. Pharmacother., January 1, 2004; 38(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. B. Chauhan Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease J. Lipid Res., November 1, 2003; 44(11): 2019 - 2029. [Abstract] [Full Text]
|
|
|
|
|
|
G. Xu, H. Li, L.-x. Pan, Q. Shang, A. Honda, M. Ananthanarayanan, S. K. Erickson, B. L. Shneider, S. Shefer, J. Bollineni, et al. FXR-mediated down-regulation of CYP7A1 dominates LXR{alpha} in long-term cholesterol-fed NZW rabbits J. Lipid Res., October 1, 2003; 44(10): 1956 - 1962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Xie, E. G. Lund, S. D. Turley, D. W. Russell, and J. M. Dietschy Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration J. Lipid Res., September 1, 2003; 44(9): 1780 - 1789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Lund, C. Xie, T. Kotti, S. D. Turley, J. M. Dietschy, and D. W. Russell Knockout of the Cholesterol 24-Hydroxylase Gene in Mice Reveals a Brain-specific Mechanism of Cholesterol Turnover J. Biol. Chem., June 13, 2003; 278(25): 22980 - 22988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Leoni, T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, and I. Bjorkhem Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers J. Lipid Res., April 1, 2003; 44(4): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wolozin Cyp46 (24S-Cholesterol Hydroxylase): A Genetic Risk Factor for Alzheimer Disease Arch Neurol, January 1, 2003; 60(1): 16 - 18. [Full Text] [PDF]
|
|
|
|
|
|
A. Papassotiropoulos, J. R. Streffer, M. Tsolaki, S. Schmid, D. Thal, F. Nicosia, V. Iakovidou, A. Maddalena, D. Lutjohann, E. Ghebremedhin, et al. Increased Brain {beta}-Amyloid Load, Phosphorylated Tau, and Risk of Alzheimer Disease Associated With an Intronic CYP46 Polymorphism Arch Neurol, January 1, 2003; 60(1): 29 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Meaney, K. Bodin, U. Diczfalusy, and I. Bjorkhem On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function J. Lipid Res., December 1, 2002; 43(12): 2130 - 2135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bodin, U. Andersson, E. Rystedt, E. Ellis, M. Norlin, I. Pikuleva, G. Eggertsen, I. Bjorkhem, and U. Diczfalusy Metabolism of 4beta -Hydroxycholesterol in Humans J. Biol. Chem., August 23, 2002; 277(35): 31534 - 31540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. L. Chiang Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors Endocr. Rev., August 1, 2002; 23(4): 443 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lutjohann, A. Brzezinka, E. Barth, D. Abramowski, M. Staufenbiel, K. von Bergmann, K. Beyreuther, G. Multhaup, and T. A. Bayer Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain J. Lipid Res., July 1, 2002; 43(7): 1078 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Whitney, M. A. Watson, J. L. Collins, W. G. Benson, T. M. Stone, M. J. Numerick, T. K. Tippin, J. G. Wilson, D. A. Winegar, and S. A. Kliewer Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System Mol. Endocrinol., June 1, 2002; 16(6): 1378 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. B. Javitt 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles J. Lipid Res., May 1, 2002; 43(5): 665 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bjorkhem and U. Diczfalusy Oxysterols: Friends, Foes, or Just Fellow Passengers? Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 734 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Locatelli, D. Lutjohann, H. H.-J. Schmidt, C. Otto, U. Beisiegel, and K. von Bergmann Reduction of Plasma 24S-Hydroxycholesterol (Cerebrosterol) Levels Using High-Dosage Simvastatin in Patients With Hypercholesterolemia: Evidence That Simvastatin Affects Cholesterol Metabolism in the Human Brain Arch Neurol, February 1, 2002; 59(2): 213 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schwarz, D. W. Russell, J. M. Dietschy, and S. D. Turley Alternate pathways of bile acid synthesis in the cholesterol 7{alpha}-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding J. Lipid Res., October 1, 2001; 42(10): 1594 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Simons, P. Keller, J. Dichgans, and J. B. Schulz Cholesterol and Alzheimer's disease: Is there a link? Neurology, September 25, 2001; 57(6): 1089 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, D. Li, D. E. Blanchard, S. R. Lear, S. K. Erickson, and T. A. Spencer Key regulatory oxysterols in liver: analysis as {{Delta}}4-3-ketone derivatives by HPLC and response to physiological perturbations J. Lipid Res., April 1, 2001; 42(4): 649 - 658. [Abstract] [Full Text]
|
|
|
|
|
|
I. Björkhem, L. Starck, U. Andersson, D. Lütjohann, S. von Bahr, I. Pikuleva, A. Babiker, and U. Diczfalusy Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol J. Lipid Res., March 1, 2001; 42(3): 366 - 371. [Abstract] [Full Text]
|
|
|
|
|
|
S. Meaney, M. Hassan, A. Sakinis, D. Lütjohann, K. von Bergmann, A. Wennmalm, U. Diczfalusy, and I. Björkhem Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study J. Lipid Res., January 1, 2001; 42(1): 70 - 78. [Abstract] [Full Text]
|
|
|
|
|
|
M. Norlin, A. Toll, I. Björkhem, and K. Wikvall 24-Hydroxycholesterol is a substrate for hepatic cholesterol 7{alpha}-hydroxylase (CYP7A) J. Lipid Res., October 1, 2000; 41(10): 1629 - 1639. [Abstract] [Full Text]
|
|
|
|
|
|
R. W. Haley and J. M. Dietschy Is There a Connection Between the Concentration of Cholesterol Circulating in Plasma and the Rate of Neuritic Plaque Formation in Alzheimer Disease? Arch Neurol, October 1, 2000; 57(10): 1410 - 1412. [Full Text] [PDF]
|
|
|
|
|
|
L. Bretillon, D. Lütjohann, L. Ståhle, T. Widhe, L. Bindl, G. Eggertsen, U. Diczfalusy, and I. Björkhem Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface J. Lipid Res., May 1, 2000; 41(5): 840 - 845. [Abstract] [Full Text]
|
|
|
|
|
|
D. Lütjohann, A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli, R. D. Oehring, U. Schlegel, F. Jessen, M. L. Rao, K. von Bergmann, et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients J. Lipid Res., February 1, 2000; 41(2): 195 - 198. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Laitinen, V. M. Olkkonen, C. Ehnholm, and E. Ikonen Family of human oxysterol binding protein (OSBP) homologues: a novel member implicated in brain sterol metabolism J. Lipid Res., December 1, 1999; 40(12): 2204 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Lund, J. M. Guileyardo, and D. W. Russell cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain PNAS, June 22, 1999; 96(13): 7238 - 7243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li-Hawkins, E. G. Lund, A. D. Bronson, and D. W. Russell Expression Cloning of an Oxysterol 7alpha -Hydroxylase Selective for 24-Hydroxycholesterol J. Biol. Chem., May 26, 2000; 275(22): 16543 - 16549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Baes, S. Huyghe, P. Carmeliet, P. E. Declercq, D. Collen, G. P. Mannaerts, and P. P. Van Veldhoven Inactivation of the Peroxisomal Multifunctional Protein-2 in Mice Impedes the Degradation of Not Only 2-Methyl-branched Fatty Acids and Bile Acid Intermediates but Also of Very Long Chain Fatty Acids J. Biol. Chem., May 19, 2000; 275(21): 16329 - 16336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bjorkhem, U. Andersson, E. Ellis, G. Alvelius, L. Ellegard, U. Diczfalusy, J. Sjovall, and C. Einarsson From Brain to Bile. EVIDENCE THAT CONJUGATION AND omega -HYDROXYLATION ARE IMPORTANT FOR ELIMINATION OF 24S-HYDROXYCHOLESTEROL (CEREBROSTEROL) IN HUMANS J. Biol. Chem., September 28, 2001; 276(40): 37004 - 37010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Dietschy and S. D. Turley Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal J. Lipid Res., August 1, 2004; 45(8): 1375 - 1397. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |